Molecularly Targeted Drug Delivery Systems, Nanoparticles, Nanoconjugates, Prodrugs, Anticancer Drugs, Cancer Metastasis, Nanotechnology, Chemical Synthesis, Cancer Biology, Imaging Methods
My research interest is to develop molecularly targeted drug delivery systems, such as nanoparticles, nanoconjugates and prodrugs, to improve tumor specific delivery of anticancer drugs and biologics to target cancer metastasis. My research uses pharmacokinetic and pharmacodynamic principles and employs multidisciplinary approaches, including nanotechnology, chemical synthesis, cancer biology, and imaging methods, to study the disposition and efficacy of the nanotherapeutics in preclinical cancer models. Currently, my research focuses on two main areas: 1) rational design and development of novel nanoparticles and nanoconjugates that can overcome various physiological and biological barriers (such as blood brain barrier), selectively accumulate at specific anatomical locations such as CNS and bone, efficiently target cancer metastasis, and eradicate tumor cells without harming normal cells; and 2) preclinical evaluations of novel anticancer drug combination and drug delivery systems that can overcome multidrug resistance.
Publications/Creative Works
Click here to search for this faculty member's publications on PubMed.
Important Disclaimer: The responsibility for the accuracy of the information contained on these pages lies with the authors and user providing such information.